A型肉毒毒素治疗贲门失弛缓及远期疗效观察

来源 :现代康复 | 被引量 : 0次 | 上传用户:yt2099
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 评价内镜下注射肉毒毒素治疗贲门失弛缓的临床效果。方法 对 57例贲门失弛缓病人采用内镜下注射 A型肉毒毒素治疗,通过对治疗前后主要症状评分及食管下括约肌压力( LESP)测定评价近期疗效。治疗后半年、 1年、 2年随访,评价中远期疗效。结果 在 57例病人中有 54例治疗后症状缓解占 95%,无合并症发生。随访观察治疗后半年以上有 41例,其中 36例未复发占 88%; 1年以上 30例,有 25例未复发占 83%; 2年以上 12例,有 8例未复发占 67%。结论 内镜下注射 A型肉毒毒素治疗贲门失弛缓是一简单、安全、有效的方法。 Objective To evaluate the clinical efficacy of endoscopic injection of botulinum toxin in the treatment of achalasia. Methods Fifty-seven patients with achalasia were treated by endoscopic injection of botulinum toxin type A, and the short-term efficacy was evaluated by the main symptom scores and the lower esophageal sphincter pressure (LESP) before and after treatment. Six months after treatment, 1 year, 2 years follow-up, evaluation of long-term efficacy. Results In 57 patients, 54 patients had 95% of symptom relief after treatment, and no complications occurred. Follow-up After treatment for more than six months, there were 41 cases, of which 36 cases did not recurrence accounted for 88%; 1 year or more in 30 cases, 25 cases of non-recurrence accounted for 83%; 2 years or more in 12 cases, 8 cases of 67%. Conclusion Endoscopic injection of botulinum toxin A is a simple, safe and effective method for the treatment of achalasia.
其他文献